Cargando…

High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis

We have identified a population of T lymphocytes in peripheral blood, Vδ1 TCRγδ T lymphocytes, which unexpectedly was uniquely expressing high production of interferon-γ in newly diagnosed, untreated multiple sclerosis (MS) patients. IFN-γ production in this population distinctly correlated to param...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Avadhesh Kumar, Novakova, Lenka, Axelsson, Markus, Malmeström, Clas, Zetterberg, Henrik, Lycke, Jan, Cardell, Susanna L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343019/ https://www.ncbi.nlm.nih.gov/pubmed/28337205 http://dx.doi.org/10.3389/fimmu.2017.00260

Ejemplares similares

Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2023)

A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis
por: Sandgren, Sofia, et al.
Publicado: (2023)

Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers
por: Novakova, Lenka, et al.
Publicado: (2018)

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis
por: Sandelius, Åsa, et al.
Publicado: (2019)

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
por: Novakova, Lenka, et al.
Publicado: (2017)

The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective survey
por: Sandgren, Sofia, et al.
Publicado: (2023)

No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab
por: Johnsson, Magnus, et al.
Publicado: (2022)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
por: Huang, Jesse, et al.
Publicado: (2020)

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)
por: Jernås, Margareta, et al.
Publicado: (2013)

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2022)

High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2023)

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study
por: Zhukovsky, Christina, et al.
Publicado: (2021)

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy
por: Salzer, Jonatan, et al.
Publicado: (2016)

Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study
por: Rosenstein, Igal, et al.
Publicado: (2021)

SARS‐COV‐2 a trigger of myelin oligodendrocyte glycoprotein‐associated disorder
por: Johnsson, Magnus, et al.
Publicado: (2022)

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
por: Hermansson, Linn, et al.
Publicado: (2019)

Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells
por: Wang, Ying, et al.
Publicado: (2017)

Neuronal antibodies in adult patients with new‐onset seizures: A prospective study
por: Zelano, Johan, et al.
Publicado: (2019)

A Sensitive Method for Detecting Peptide-specific CD4(+) T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis
por: Sharma, Sapna, et al.
Publicado: (2017)

Type II NKT Cells: An Elusive Population With Immunoregulatory Properties
por: Singh, Avadhesh Kumar, et al.
Publicado: (2018)

Axonal Damage in Pediatric Multiple Sclerosis
por: Kuntz, Nancy L.
Publicado: (2015)

Defining a novel subset of CD1d‐dependent type II natural killer T cells using natural killer cell‐associated markers
por: Singh, Avadhesh Kumar, et al.
Publicado: (2019)

CSF orexin-A levels after rituximab treatment in recent onset narcolepsy type 1
por: Wasling, Pontus, et al.
Publicado: (2019)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
por: Skillbäck, Tobias, et al.
Publicado: (2013)

Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis
por: Jons, Daniel, et al.
Publicado: (2022)

Long-term use of interferon-β in multiple sclerosis increases Vδ1(−)Vδ2(−)Vγ9(−) γδ T cells that are associated with a better outcome
por: Maimaitijiang, Guzailiayi, et al.
Publicado: (2019)

Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection
por: Cimini, Eleonora, et al.
Publicado: (2012)

Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
por: Lee, Mijeong, et al.
Publicado: (2019)

Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGF(δ/δ )mouse model of amyotrophic lateral sclerosis
por: Brockington, Alice, et al.
Publicado: (2010)

An observational study of alemtuzumab following fingolimod for multiple sclerosis
por: Willis, Mark, et al.
Publicado: (2017)

Characteristics of peripheral Vγ2Vδ2 T cells in interferon-γ release assay negative pulmonary tuberculosis patients
por: Yan, Liping, et al.
Publicado: (2018)

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination
por: Schultz, Verena, et al.
Publicado: (2017)

Lifespan of γ/δ T Cells
por: Tough, David F., et al.
Publicado: (1998)

New γ-Halo-δ-lactones and δ-Hydroxy-γ-lactones with Strong Cytotoxic Activity
por: Kamizela, Angelika, et al.
Publicado: (2019)

Peripherin is a biomarker of axonal damage in peripheral nervous system disease
por: Keddie, Stephen, et al.
Publicado: (2023)

Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis
por: Singh, Shailender, et al.
Publicado: (2017)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

The extracellular matrix of lymph node reticular fibers modulates follicle border interactions and germinal center formation
por: Song, Jian, et al.
Publicado: (2023)

Increasing Affinity of Interferon-γ Receptor 1 to Interferon-γ by Computer-Aided Design
por: Mikulecký, Pavel, et al.
Publicado: (2013)

The Role of the γ δ T Cell in Allergic Diseases
por: Zheng, Rui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1m35rlbkl72sopvi6tnjmcg8vs